Related Experiment Video
Updated: Mar 2, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
The management of moderate-to-severe chronic plaque psoriasis
Annalisa Tonini1, Salvatore Panduri1, Angelo M D' Erme1,2
1Department of Dermatology, University of Pisa, Pisa, Italy.
Abstract:
Recent approval and marketization of novel treatments have widened the range of therapeutic opportunities for moderate-to-severe psoriasis. In the next years, this panorama will be further enlarged as many other agents, both oral small molecules and biologics, have passed phase III and are expected to be approved, and subsequently marketed, shortly. In spite of this array of therapeutic possibilities, there is still an unmet need for an appropriate treatment in a large number of cases. This review was aimed to describe general principles regarding the therapeutic approach to moderate-severe plaque psoriasis, providing an updated overview of the therapeutic armamentarium that is specifically available in Italy, drug prescriptibility, and some peculiar limitations for reimbursement defined by our National Health Care System.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Rheumatic Heart Disease III: Medical Management

